Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease - 17 days ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 7 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 8 months ago Glucose Changes in Type 1 Diabetes May Affect Thinking Speed - 12 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 12 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - about 1 year ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - about 1 year ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - about 1 year ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - about 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - over 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - over 1 year ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 22 days ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 11 months ago
3	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial? - 25 days ago Diabetes Drug Shows Benefit in Parkinson's Disease - 11 months ago Can a GLP-1 Agonist Improve Parkinson's Symptoms? - about 1 year ago
4	Elizabeth Rayne Ars Technica Scribe @arstechnica @denofgeek @unclekrust. the void Writing	Craving carbs? Blame an ancient gene. - 2 months ago
5	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Leveraging Recombinant Kinases for Drug Discovery Research - 2 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender - 2 months ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 8 months ago
7	Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. scienceediting	The Regulation of the lac Operon - 3 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 3 months ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 3 months ago
10	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Metformin Use Linked to Fewer Asthma Attacks - 3 months ago The GLP-1 Agonist Plateau No One's Talking About - over 1 year ago

Journalists covering glucokinase